Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

NeuroSync

Explore full profile

Neuro-technology with foundational ip in eye-tracking metrics and devices

Holliston, United StatesFounded 2008Biotech & Life Sciences
Valuation $10–25M Last recorded · 2018
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for NeuroSync and the history behind them.

About NeuroSync

NeuroSync Inc., operating as neurosync.health, is a neurotechnology firm providing a digital health platform for brain health applications. Originally founded as SyncThink in 2009 by Dr. Jam Ghajar, a neurosurgeon, the company rebranded in 2022 to better reflect its expanding focus on the broader neurological healthcare market. Dr. Ghajar's background as the founder of the Brain Trauma Foundation underpins the company's clinical and research-driven approach. The company is headquartered in Holliston, Massachusetts, and has a presence in Palo Alto, California. A significant milestone was achieved in September 2022 when the company, then known as SyncThink, rebranded to NeuroSync under a new executive team to accelerate its growth within the larger neuro-healthcare landscape.

The company's core business revolves around a digital platform that utilizes artificial intelligence and objective measurements to assess brain health, provide therapy, and enhance cognitive performance. NeuroSync serves a diverse client base that includes healthcare organizations, biopharmaceutical companies, sports teams, and the military. Clients use the platform for various purposes, from identifying neurological deficits and monitoring treatment responses to planning targeted training programs. The business model involves providing access to its proprietary software and analytics, with revenue generated from partnerships and the sale of its integrated technology solutions. Key partners include Stanford University, Magic Leap, and the Department of Defense.

NeuroSync's flagship product is EYE-SYNC®, an FDA-cleared technology that uses eye-tracking within a virtual reality (VR) headset to assess brain health. The platform comes as a package including a VR headset, a tablet, and a suite of eye-tracking assessments. EYE-SYNC can analyze eye movements as an aid in diagnosing conditions like concussions and is backed by numerous patents and peer-reviewed publications. It provides clinicians with detailed reports, metrics, and visuals to describe a patient's performance, identifying the type and severity of dysfunction. A second product, PRO-SYNC, is a non-medical wellness application designed to track and enhance sleep quality and mental acuity by monitoring eye movements, providing users with a readiness score. Unlike EYE-SYNC, which is a registered medical device, PRO-SYNC is positioned as a general wellness tool. Both products leverage proprietary algorithms to quantify synchronization abilities and provide actionable data in minutes.

Source: Dealroom company data

At a glance

Founded
2008
Headquarters
Holliston, United States
Sector
Biotech & Life Sciences

Investors

8 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed7 investors entered at this stage

  • Alan Quasha
  • Quadrant Management
  • US Department of War
  • Brain Trauma Foundation
  • MassChallenge
  • StartUp Health
  • Delaware Division of Small Business

Series A1 investor entered at this stage

  • Oceanic Partners
Team profiled 10 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
2 countries with
team presence
🇺🇸 United States90.3%
🇵🇰 Pakistan9.7%
2 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about NeuroSync on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See NeuroSync on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.